ULTRALIFE CORP (ULBI) - Form 8-K Summary
Business Context and Reporting Period
Ultralife Corporation, a Delaware corporation, filed this Current Report on Form 8-K on March 10, 2026. The filing serves to announce the financial results for the fourth quarter ended December 31, 2025. The company's common stock trades on the NASDAQ Stock Market under the symbol ULBI.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These details are contained within the press release attached as Exhibit 99.1, which is incorporated by reference but not included in the provided text.
Material Changes
No material changes or comparative financial data versus prior periods are disclosed in the body of this Form 8-K. The document solely references the issuance of the press release regarding the Q4 2025 results.
Guidance, Outlook, and Risks
The filing does not contain management commentary, forward-looking guidance, risk factors, or details on contingencies and unusual items. Such information is presumed to be located in the referenced press release (Exhibit 99.1).
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated March 10, 2026) for specific Q4 2025 revenue and earnings figures.
- Verify year-over-year growth rates and margin trends in the full press release.
- Check for any updated full-year 2025 guidance or 2026 outlook provided in the referenced exhibit.
- Confirm the absence of any restatements or unusual items in the detailed financial disclosure.